CRP and rheumatoid arthritis: This study encourages the consideration of a global pool of validated composite indices (DAS28-ESR, DAS28-CRP, CDAI, and SDAI) to measure rheumatoid arthritis disease activity, thus individualizing the target value based on patient-related factors, as advocated by the T2T strategy [2,3].